We provide you with 20 years of free, institutional-grade data for MNOV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MNOV. Explore the full financial landscape of MNOV stock.
| Reported Date | CIK | Ticker | Type |
|---|
MediciNova, Inc(NASDAQ:MNOV) 
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treati...
Website: http://medicinova.com
Founded: 2000
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MNOV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.